Clockwise from left) Jeffery Kelly, H. Lutcher Brown Professor of Chemistry; Travis Young, executive vice president of Calibr-Skaggs Institute for Innovative Medicines, and Isy Goldwasser, entrepreneur-in-residence at Calibr-Skaggs; Darrell Irvine, professor and vice-chair of the Department of Immunology and Microbiology, and Angel Martin, PhD.

Thought leaders from across the biotech industry convened for a powerful day of keynote addresses, fireside chats, pitches and networking during Scripps Research’s second Biotech Innovation Summit.

Last October’s event enabled attendees to engage with Scripps Research investigators pioneering early-stage innovation and showcased how strategic partnerships between academia and industry can transform breakthrough discoveries into therapies that address urgent medical needs.

From left: Keary Engle, Phil Baran, Monica Fitzgerald, Phil Dawson, Martin Eastgate and Chris Bi.

Tom Daniel, Scripps Research board member, chair and founder of Life Science Cares, and chair of Gate Bioscience, kicked off the summit with a keynote about how his career as a physician, investigator and venture partner gave him insight into how to successfully approach the biotech industry. A morning panel followed with scientists from Scripps Research and Bristol Myers Squibb examining academic-industry partnerships and the factors that have led to their own successful 13-year collaboration. Interspersed with fireside chats, Scripps Research scientists delivered compelling pitches for their research, ranging from autoimmunity and cancer to drug discovery and design.

The next Biotech Innovation Summit is slated for Thursday, October. 22, 2026 in La Jolla. Save the date and learn more by visiting techsummit.scripps.edu